Literature DB >> 2168436

Antigenic variations in bovine viral diarrhea viruses detected by monoclonal antibodies.

W Xue1, F Blecha, H C Minocha.   

Abstract

Five murine monoclonal antibodies (MAbs) against the NADL strain of bovine viral diarrhea (BVD) virus were developed, identified, and characterized. Four of the MAbs were directed against a 53-kilodalton (kDa) viral protein, and one was specific to a 47-kDa polypeptide. Competitive radioimmunoassay showed that two MAbs were specific to related epitopes of the 53-kDa protein, and the other three MAbs were each specific to a different epitope. The MAbs were used to study heterogeneity among BVD virus strains. Various degrees of reactivity of cytopathic and noncytopathic virus isolates were detected by virus neutralization and immunofluorescence assays. The virus isolates were divided into six groups based on the neutralization test. The results indicated that the 53-kDa glycoprotein of BVD virus is the major protein involved in virus neutralization and that only a few epitopes of the protein contribute to the neutralization. None of the MAbs neutralized all the BVD virus isolates tested in this study, suggesting antigenic variations among BVD virus isolates.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168436      PMCID: PMC268028          DOI: 10.1128/jcm.28.8.1688-1693.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Effects of parasympathominetics on porcine stillbirth.

Authors:  D J Sprecher; A D Leman; S Carlisle
Journal:  Am J Vet Res       Date:  1975-09       Impact factor: 1.156

Review 2.  Bovine viral diarrhea virus: a review.

Authors:  J C Baker
Journal:  J Am Vet Med Assoc       Date:  1987-06-01       Impact factor: 1.936

3.  Typing of cytopathic and noncytopathic bovine viral diarrhea virus reference and Canadian field strains using a neutralizing monoclonal antibody.

Authors:  R Magar; H C Minocha; C Montpetit; P S Carman; J Lecomte
Journal:  Can J Vet Res       Date:  1988-01       Impact factor: 1.310

4.  Monoclonal antibodies with neutralizing activity segregate isolates of bovine viral diarrhea virus into groups. Brief report.

Authors:  S Bolin; V Moennig; N E Kelso Gourley; J Ridpath
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

5.  Glycoproteins of bovine viral diarrhoea-mucosal disease virus in infected bovine cells.

Authors:  R O Donis; E J Dubovi
Journal:  J Gen Virol       Date:  1987-06       Impact factor: 3.891

6.  Variation in the intracellular polypeptide profiles from different isolates of bovine virus diarrhoea virus.

Authors:  D H Pocock; C J Howard; M C Clarke; J Brownlie
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

7.  Comparison by the neutralisation assay of pairs of non-cytopathogenic and cytopathogenic strains of bovine virus diarrhoea virus isolated from cases of mucosal disease.

Authors:  C J Howard; J Brownlie; M C Clarke
Journal:  Vet Microbiol       Date:  1987-04       Impact factor: 3.293

Review 8.  Pathogenesis and epidemiology of border disease.

Authors:  P F Nettleton
Journal:  Ann Rech Vet       Date:  1987

9.  Preliminary serological characterization of bovine viral diarrhoea virus strains using monoclonal antibodies.

Authors:  W Peters; I Greiser-Wilke; V Moennig; B Liess
Journal:  Vet Microbiol       Date:  1986-09       Impact factor: 3.293

10.  New concepts in the pathogenesis, diagnosis and control of diseases caused by the bovine viral diarrhea virus.

Authors:  O M Radostits; I R Littlejohns
Journal:  Can Vet J       Date:  1988-06       Impact factor: 1.008

View more
  13 in total

1.  Expression of a 50 kDa putative receptor for bovine viral diarrhea virus in bovine fetal tissues.

Authors:  L Zheng; S Zhang; W Xue; S Kapil; H C Minocha
Journal:  Can J Vet Res       Date:  1998-04       Impact factor: 1.310

2.  Neutralizing antibodies to type 1 and 2 bovine viral diarrhea viruses: detection by inhibition of viral cytopathology and infectivity by immunoperoxidase assay.

Authors:  R W Fulton; J T Saliki; L J Burge; J M d'Offay; S R Bolin; R K Maes; J C Baker; M L Frey
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

3.  Immune suppression in calves with bovine immunodeficiency virus.

Authors:  S Zhang; C Wood; W Xue; S M Krukenberg; Q Chen; H C Minocha
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

4.  Antigenic variation among bovine viral diarrhea virus (BVDV) strains and the role of different cell fixation methods in immunoassays.

Authors:  S M Elahi; S Harpin; E Cornaglia; B Talbot; Y Elazhary
Journal:  Can J Vet Res       Date:  1997-01       Impact factor: 1.310

Review 5.  Bovine viral diarrhea virus: biotypes and disease.

Authors:  D Deregt; K G Loewen
Journal:  Can Vet J       Date:  1995-06       Impact factor: 1.008

6.  Antigenic differences between a field isolate and vaccine strains of bovine viral diarrhea virus.

Authors:  J R Reddy; W Xue; S Rivera; H C Minocha
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

7.  Detection of inhibition of bovine viral diarrhea virus by aromatic cationic molecules.

Authors:  M Daniel Givens; Christine C Dykstra; Kenny V Brock; David A Stringfellow; Arvind Kumar; Chad E Stephens; Hakan Goker; David W Boykin
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

8.  Immune response to bovine viral diarrhea virus induced by anti-idiotypic antibodies.

Authors:  W Xue; H C Minocha
Journal:  Clin Diagn Lab Immunol       Date:  1994-01

9.  A transgenic ginseng vaccine for bovine viral diarrhea.

Authors:  Yugang Gao; Xueliang Zhao; Chao Sun; Pu Zang; He Yang; Ran Li; Lianxue Zhang
Journal:  Virol J       Date:  2015-05-07       Impact factor: 4.099

10.  Generation of the bovine viral diarrhea virus e0 protein in transgenic astragalus and its immunogenicity in sika deer.

Authors:  Yugang Gao; Xueliang Zhao; Pu Zang; Qun Liu; Gongqing Wei; Lianxue Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-22       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.